Qingqing Cai
Sun Yat-sen Universitiy Cancer Center · Sun Yat-Sen University Cancer Center · Sun yat-sen university cancer cente
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Qingqing Cai as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07550855 · Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular LymphomaSun Yat-sen University · not yet recruiting · Follicular Lymphoma (FL) · principal investigator
- Ph3NCT06947967 · Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeChipscreen Biosciences, Ltd. · recruiting · Lymphoma, T-Cell, Peripheral · principal investigator
- Ph2NCT06517511 · Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)Sun Yat-sen University · recruiting · Diffuse Large B Cell Lymphoma · principal investigator
- Ph1NCT06251180 · Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin LymphomaGuangzhou Lupeng Pharmaceutical Company LTD. · active not recruiting · B-cell Non-Hodgkin Lymphoma · study chair
- Ph2NCT05572983 · Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeSun Yat-sen University · unknown · Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype · study director
- Ph2NCT04996758 · Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)Sun Yat-sen University · completed · Nasopharyngeal Carcinoma, Recurrent or Metastatic Nasopharyngeal Carcinoma · principal investigator
- Ph2NCT04989621 · Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)Sun Yat-sen University · recruiting · Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma · study director
- Ph2NCT04797182 · Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With LymphomaSun Yat-sen University · unknown · Thrombocytopenia, Cytarabine Causing Adverse Effects in Therapeutic Use, Lymphoma · principal investigator
- Ph2NCT04624984 · PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHLSun Yat-sen University · unknown · Classical Hodgkin Lymphoma, Refractory or Relapsed Classical Hodgkin Lymphoma · principal investigator
- Ph2NCT04624958 · Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCLSun Yat-sen University · active not recruiting · Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma · principal investigator
- Ph2NCT04329130 · Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell LymphomaSun Yat-sen University · unknown · Relapsed or Refractory Peripheral T-cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:54 UTC. The ranking covers the 200 most relevant of 134 PubMed records, and a shared surname and initials can bring in a namesake. All 134 on PubMed
- New human-specific brain landmark: the depth asymmetry of superior temporal sulcus.Proc Natl Acad Sci U S A · 2015128 citationsRCR 5.0
- 127 citationsRCR 2.8
- Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.J Transl Med · 2007100 citationsRCR 2.1
- Effects of Simulation-Based Deliberate Practice on Nursing Students' Communication, Empathy, and Self-Efficacy.J Nurs Educ · 201984 citationsRCR 9.2
- Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.Signal Transduct Target Ther · 202076 citationsRCR 3.0
- 65 citationsRCR 8.9
- 60 citationsRCR 3.1
- The Effect of rTMS over the Different Targets on Language Recovery in Stroke Patients with Global Aphasia: A Randomized Sham-Controlled Study.Biomed Res Int · 201958 citationsRCR 4.0
- 48 citationsRCR 2.0
- 45 citationsRCR 2.2